Evolution of NETosis markers and DAMPs have prognostic value in critically ill COVID-19 patients
Abstract Coronavirus disease 19 (COVID-19) presents with disease severities of varying degree. In its most severe form, infection may lead to respiratory failure and multi-organ dysfunction. Here we study the levels and evolution of the damage associated molecular patterns (DAMPS) cell free DNA (cfD...
Guardado en:
| Autores principales: | , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Nature Portfolio
2021
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/42f33b11eed544279e2c99d11b536402 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:42f33b11eed544279e2c99d11b536402 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:42f33b11eed544279e2c99d11b5364022021-12-02T16:36:36ZEvolution of NETosis markers and DAMPs have prognostic value in critically ill COVID-19 patients10.1038/s41598-021-95209-x2045-2322https://doaj.org/article/42f33b11eed544279e2c99d11b5364022021-08-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-95209-xhttps://doaj.org/toc/2045-2322Abstract Coronavirus disease 19 (COVID-19) presents with disease severities of varying degree. In its most severe form, infection may lead to respiratory failure and multi-organ dysfunction. Here we study the levels and evolution of the damage associated molecular patterns (DAMPS) cell free DNA (cfDNA), extracellular histone H3 (H3) and neutrophil elastase (NE), and the immune modulators GAS6 and AXL in relation to clinical parameters, ICU scoring systems and mortality in patients (n = 100) with severe COVID-19. cfDNA, H3, NE, GAS6 and AXL were increased in COVID-19 patients compared to controls. These measures associated with occurrence of clinical events and intensive care unit acquired weakness (ICUAW). cfDNA and GAS6 decreased in time in patients surviving to 30 days post ICU admission. A decrease of 27.2 ng/mL cfDNA during ICU stay associated with patient survival, whereas levels of GAS6 decreasing more than 4.0 ng/mL associated with survival. The presence of H3 in plasma was a common feature of COVID-19 patients, detected in 38% of the patients at ICU admission. NETosis markers cfDNA, H3 and NE correlated well with parameters of tissue damage and neutrophil counts. Furthermore, cfDNA correlated with lowest p/f ratio and a lowering in cfDNA was observed in patients with ventilator-free days.Joram HuckriedeSara Bülow AnderbergAlbert MoralesFemke de VriesMichael HultströmAnders BergqvistJosé T. Ortiz-PérezJan Willem SelsKanin WichapongMiklos LipcseyMarcel van de PollAnders LarssonTomas LutherChris ReutelingspergerPablo Garcia de FrutosRobert FrithiofGerry A. F. NicolaesNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-12 (2021) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Medicine R Science Q |
| spellingShingle |
Medicine R Science Q Joram Huckriede Sara Bülow Anderberg Albert Morales Femke de Vries Michael Hultström Anders Bergqvist José T. Ortiz-Pérez Jan Willem Sels Kanin Wichapong Miklos Lipcsey Marcel van de Poll Anders Larsson Tomas Luther Chris Reutelingsperger Pablo Garcia de Frutos Robert Frithiof Gerry A. F. Nicolaes Evolution of NETosis markers and DAMPs have prognostic value in critically ill COVID-19 patients |
| description |
Abstract Coronavirus disease 19 (COVID-19) presents with disease severities of varying degree. In its most severe form, infection may lead to respiratory failure and multi-organ dysfunction. Here we study the levels and evolution of the damage associated molecular patterns (DAMPS) cell free DNA (cfDNA), extracellular histone H3 (H3) and neutrophil elastase (NE), and the immune modulators GAS6 and AXL in relation to clinical parameters, ICU scoring systems and mortality in patients (n = 100) with severe COVID-19. cfDNA, H3, NE, GAS6 and AXL were increased in COVID-19 patients compared to controls. These measures associated with occurrence of clinical events and intensive care unit acquired weakness (ICUAW). cfDNA and GAS6 decreased in time in patients surviving to 30 days post ICU admission. A decrease of 27.2 ng/mL cfDNA during ICU stay associated with patient survival, whereas levels of GAS6 decreasing more than 4.0 ng/mL associated with survival. The presence of H3 in plasma was a common feature of COVID-19 patients, detected in 38% of the patients at ICU admission. NETosis markers cfDNA, H3 and NE correlated well with parameters of tissue damage and neutrophil counts. Furthermore, cfDNA correlated with lowest p/f ratio and a lowering in cfDNA was observed in patients with ventilator-free days. |
| format |
article |
| author |
Joram Huckriede Sara Bülow Anderberg Albert Morales Femke de Vries Michael Hultström Anders Bergqvist José T. Ortiz-Pérez Jan Willem Sels Kanin Wichapong Miklos Lipcsey Marcel van de Poll Anders Larsson Tomas Luther Chris Reutelingsperger Pablo Garcia de Frutos Robert Frithiof Gerry A. F. Nicolaes |
| author_facet |
Joram Huckriede Sara Bülow Anderberg Albert Morales Femke de Vries Michael Hultström Anders Bergqvist José T. Ortiz-Pérez Jan Willem Sels Kanin Wichapong Miklos Lipcsey Marcel van de Poll Anders Larsson Tomas Luther Chris Reutelingsperger Pablo Garcia de Frutos Robert Frithiof Gerry A. F. Nicolaes |
| author_sort |
Joram Huckriede |
| title |
Evolution of NETosis markers and DAMPs have prognostic value in critically ill COVID-19 patients |
| title_short |
Evolution of NETosis markers and DAMPs have prognostic value in critically ill COVID-19 patients |
| title_full |
Evolution of NETosis markers and DAMPs have prognostic value in critically ill COVID-19 patients |
| title_fullStr |
Evolution of NETosis markers and DAMPs have prognostic value in critically ill COVID-19 patients |
| title_full_unstemmed |
Evolution of NETosis markers and DAMPs have prognostic value in critically ill COVID-19 patients |
| title_sort |
evolution of netosis markers and damps have prognostic value in critically ill covid-19 patients |
| publisher |
Nature Portfolio |
| publishDate |
2021 |
| url |
https://doaj.org/article/42f33b11eed544279e2c99d11b536402 |
| work_keys_str_mv |
AT joramhuckriede evolutionofnetosismarkersanddampshaveprognosticvalueincriticallyillcovid19patients AT sarabulowanderberg evolutionofnetosismarkersanddampshaveprognosticvalueincriticallyillcovid19patients AT albertmorales evolutionofnetosismarkersanddampshaveprognosticvalueincriticallyillcovid19patients AT femkedevries evolutionofnetosismarkersanddampshaveprognosticvalueincriticallyillcovid19patients AT michaelhultstrom evolutionofnetosismarkersanddampshaveprognosticvalueincriticallyillcovid19patients AT andersbergqvist evolutionofnetosismarkersanddampshaveprognosticvalueincriticallyillcovid19patients AT josetortizperez evolutionofnetosismarkersanddampshaveprognosticvalueincriticallyillcovid19patients AT janwillemsels evolutionofnetosismarkersanddampshaveprognosticvalueincriticallyillcovid19patients AT kaninwichapong evolutionofnetosismarkersanddampshaveprognosticvalueincriticallyillcovid19patients AT mikloslipcsey evolutionofnetosismarkersanddampshaveprognosticvalueincriticallyillcovid19patients AT marcelvandepoll evolutionofnetosismarkersanddampshaveprognosticvalueincriticallyillcovid19patients AT anderslarsson evolutionofnetosismarkersanddampshaveprognosticvalueincriticallyillcovid19patients AT tomasluther evolutionofnetosismarkersanddampshaveprognosticvalueincriticallyillcovid19patients AT chrisreutelingsperger evolutionofnetosismarkersanddampshaveprognosticvalueincriticallyillcovid19patients AT pablogarciadefrutos evolutionofnetosismarkersanddampshaveprognosticvalueincriticallyillcovid19patients AT robertfrithiof evolutionofnetosismarkersanddampshaveprognosticvalueincriticallyillcovid19patients AT gerryafnicolaes evolutionofnetosismarkersanddampshaveprognosticvalueincriticallyillcovid19patients |
| _version_ |
1718383627545346048 |